Metacrine Company
Developing differentiated therapies that can improve the health of patients with liver and gastrointestinal (GI) diseases
Technology:
Immunotherapy
Industry:
Biotechnology, Health Care, Medical, Pharmaceutical
Headquarters:
San Diego, California, United States
Founded Date:
2015
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
14
Total Funding:
173000000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2019
Last Funding Type:
Debt Financing
Register and Claim Ownership